Abstract:Glioblastoma (GBM) is a highly lethal brain cancer, comprising about half of all central nervous system malignancies. Its recurrence and resistance to aggressive treatments, such as surgery, radiation, and chemotherapy, underscore its biological complexity. A key feature of GBM is intra-tumoral heterogeneity (ITH), stemming from a diversity of transcriptional cell states within the tumor. While genetic contributions to ITH are well-researched, the role of non-genetic factors, especially in promoting transitions between the various transcriptional cell states (referred to as plasticity), is less understood. This plasticity enables GBM cells to survive treatment pressures, necessitating a deeper dive into the epigenetic underpinnings that govern it and the role of the tumor microenvironment (TME) in influencing it. We proposed that the TME significantly impacts the epigenetic landscape of both malignant and surrounding non-malignant cells, thereby promoting ITH and cell state plasticity. To assess this, we analyzed samples from different anatomical areas of GBM tumors collected using MRI-guided selection. Utilizing advanced multimodal single-cell sequencing technologies, we profiled the transcriptomes and epigenomes of individual cells, revealing their spatially dependent phenotypic and epigenetic diversity. Our results indicated a higher enrichment of progenitor-like malignant cells, resembling neural or oligodendrocyte progenitors, around the tumor margins. In contrast, the core mainly contained differentiated cells with mesenchymal-like characteristics. Intriguingly, progenitor-like cells in the peri-tumoral zone expressed a unique neuronal activity program, including elevated levels of PRC2 complex targets, which are critical for maintaining the pluripotency and self-renewal capabilities of neural stem cells. Additionally, our analysis of cell-cell interactions between neurons and malignant cells identified ligand-receptor pairs crucial for axon guidance, neurogenesis, and tumor invasion. Proneural factors, critical for neural differentiation, were more accessible in peri-tumoral progenitor-like cells, suggesting that malignant cells might exploit neurodevelopmental routes for growth and invasion. This work underscores the significant spatial cellular heterogeneity of GBM and the variation in epigenetic states across the tumor, demonstrating how GBM cells can hijack neurodevelopmental pathways to foster invasion. Although surgical resection can target the tumor core, our insights into the invasive mechanisms of malignant cells provide a foundation for developing targeted therapies to combat the highly invasive cells persisting in regions adjacent to the tumor. Citation Format: Federico Gaiti, Yiyan Wu, Sheila Mansouri, Benson Wu, Yosef Ellenbogen, Xuyao Li, Parnian Habibi, Joan Kant, Pathum Kossinna, Sandra Ruth Lau Rodriguez, Gelareh Zadeh. Exploring spatially resolved intra-tumoral heterogeneity of glioblastoma and neuronal mechanisms facilitating brain invasion [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 5666.

Pan-cancer analysis of the ion permeome reveals functional regulators of glioblastoma aggression

Pan-cancer ion transport signature reveals functional regulators of glioblastoma aggression

Single-Cell Transcriptomics Reveals the Heterogeneity of the Immune Landscape of IDH-Wild-Type High-Grade Gliomas

Ion channel expression patterns in glioblastoma stem cells with functional and therapeutic implications for malignancy

Potassium Ion Channel Modulation at Cancer-Neural Interface Enhances Neuronal Excitability in Epileptogenic Glioblastoma Multiforme

Myeloid cells coordinately induce glioma cell-intrinsic and cell-extrinsic pathways for chemoresistance via GP130 signaling

Patient-based multilevel transcriptome exploration highlights relevant chemokines and chemokine receptor axes in glioblastoma

Epco-58. Integrative Proteogenomic Analyses Reveal Insights Into Subtype-Specific Glioma Risk

Identification of cytokine-predominant immunosuppressive class and prognostic risk signatures in glioma

TIGIT and PD-1 Immune Checkpoint Pathways Are Associated With Patient Outcome and Anti-Tumor Immunity in Glioblastoma

Integrative genomic analysis facilitates precision strategies for glioblastoma treatment

Functional profiling of murine glioma models highlights targetable immune evasion phenotypes

Modulation of blood-tumor barrier transcriptional programs improves intra-tumoral drug delivery and potentiates chemotherapy in GBM

Network Analyses of Brain Tumor Patients' Multiomic Data Reveals Pharmacological Opportunities to Alter Cell State Transitions

Patient-derived organoids recapitulate glioma-intrinsic immune program and progenitor populations of glioblastoma

Abstract 5666: Exploring spatially resolved intra-tumoral heterogeneity of glioblastoma and neuronal mechanisms facilitating brain invasion

Electrostatic Complementarities of Glioblastoma-Resident T-Cell Receptors and Cancer Testis Antigens Linked to Poor Outcomes and High Levels of Sphingosine Kinase-2 Expression

Multiomics blueprint of PANoptosis in deciphering immune characteristics and prognosis stratification of glioma patients

Identification and validation of an anoikis-associated gene signature to predict clinical character, stemness, IDH mutation, and immune filtration in glioblastoma

Landscape of glioblastoma niches reveals the prognostic effects of tumor-infiltrating cells

Abstract 3875: Glioblastoma mutational profiles drive cancer cell signaling and immune evasion